What are the treatment options for cartilage loss in the knee?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Plan for Cartilage Loss in the Knee

Begin with a comprehensive non-pharmacological and pharmacological approach before considering surgical intervention, with treatment selection based primarily on defect size, patient age, and symptom severity. 1

Initial Non-Surgical Management

Non-Pharmacological Interventions (First-Line)

  • Patient education about osteoarthritis and self-management programs combining exercise with weight loss (if overweight/obese) are strongly recommended as foundational therapy. 1

  • Physical therapy should be offered as part of the comprehensive management plan, focusing on optimizing and maintaining joint function. 1

  • Soft braces for knee OA may provide symptomatic benefit in selected patients. 1

Pharmacological Management

Oral NSAIDs are the mainstay of pharmacologic treatment and are strongly recommended over all other oral medications for knee cartilage loss/osteoarthritis. 1 Use the lowest effective dose for the shortest duration possible, with monitoring for gastrointestinal, cardiovascular, and renal adverse effects. 1

Additional pharmacological options include:

  • Topical NSAIDs and capsaicin are recommended, particularly for patients who cannot tolerate oral NSAIDs. 1

  • Acetaminophen is conditionally recommended but has very small effect sizes; it may be appropriate for short-term use in patients with contraindications to NSAIDs (maximum 3 gm daily in divided doses with hepatotoxicity monitoring). 1

  • Duloxetine is conditionally recommended for knee OA and may provide benefit through central pain modulation. 1

  • Intra-articular corticosteroid injections are strongly recommended for symptomatic relief, providing short-term efficacy. 1 Use ultrasound guidance when available for accurate delivery, though not required for knee joints. 1

  • Intra-articular hyaluronic acid injections are an option, though corticosteroid injections are conditionally recommended over hyaluronic acid based on higher quality evidence. 1, 2

Important caveat: Glucosamine and chondroitin (SADOA) are thought to prevent cartilage degeneration but have not been shown to slow or reverse cartilage destruction. 3

Surgical Management Algorithm

Surgical intervention is indicated when conservative management fails, with technique selection based primarily on defect size and characteristics. 4, 5

Small Focal Defects (<2 cm²)

For small, contained cartilage defects:

  • Chondroplasty (surgical debridement) alone is appropriate for symptomatic relief, though it does not prevent osteoarthritis progression. 3, 4

  • Osteochondral autograft transfer is indicated for small focal defects with intact subchondral bone. 3, 4

  • Microfracture is NOT superior to chondroplasty alone and carries potential adverse effects including cyst and intralesional osteophyte formation; therefore, it should not be routinely recommended as the sole treatment. 3, 4

Critical consideration: Microfracture indications (when used) require minimal OA, a focal contained lesion <4 cm², and intact subchondral bone. 1

Medium Defects (2-3 cm²)

For defects between 2-3 cm²:

  • Microfracture with debridement remains the most frequently used approach in this size range, though controversy exists. 6

  • Consider marrow-stimulating procedures for focal defects in this range. 3

Large Defects (>3 cm²)

For larger cartilage defects exceeding 3 cm²:

  • Autologous chondrocyte implantation (ACI) or matrix-induced ACI is the primary recommendation for large defects. 3, 4, 6

  • Osteochondral allograft transfer is indicated for larger defects, particularly those involving subchondral bone. 3, 4

  • Particulated juvenile allograft cartilage shows good to excellent short-term results but lacks long-term outcome data. 4

Special Considerations

Address concomitant pathology:

  • Limb malalignment, meniscus deficiency, ligament injuries, and bone defects must be addressed to achieve successful outcomes from any cartilage restoration procedure. 4

  • Osteotomy near the knee joint is indicated for axial realignment when unilateral knee OA causes axis deviation. 3

Age considerations: Two-thirds of European surgeons consider age 50 as the upper limit or no limit for interventional cartilage surgery. 6

Critical Pitfalls to Avoid

  • Do not perform surgical debridement as the sole treatment expecting to prevent OA progression—it provides only symptomatic relief. 3

  • Do not routinely use MRI for diagnosis—plain radiography is sufficient for known or suspected OA; MRI should be reserved for specific indications. 1

  • Do not rely on microfracture alone for defects >2 cm²—it has not demonstrated superiority and may cause complications. 4

  • Recognize that fibrocartilage repair tissue (produced by most techniques) lacks the biomechanical properties of hyaline cartilage and generally deteriorates over time. 7

  • Preservation of native cartilage is always preferred if an osteochondral fragment can be salvaged. 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Cartilage Injury in the Knee: Assessment and Treatment Options.

The Journal of the American Academy of Orthopaedic Surgeons, 2020

Research

Basic science and surgical treatment options for articular cartilage injuries of the knee.

The Journal of orthopaedic and sports physical therapy, 2012

Research

Treatment of articular cartilage lesions of the knee.

International orthopaedics, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.